Our top pick for
Equitable Holdings Inc is an insurance-diversified business based in the US. Equitable shares (EQH) are listed on the NYSE and all prices are listed in US Dollars. Equitable employs 12,000 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$32.03|
|52-week range||$18.01 - $35.07|
|50-day moving average||$30.36|
|200-day moving average||$31.42|
|Wall St. target price||$43.78|
|Dividend yield||$0.69 (2.13%)|
|Earnings per share (TTM)||$-7.90|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-11)||1.42%|
|1 month (2021-09-17)||9.84%|
|3 months (2021-07-16)||11.10%|
|6 months (2021-04-16)||-4.96%|
|1 year (2020-10-16)||58.09%|
|2 years (2019-10-18)||47.54%|
|3 years (2018-10-18)||54.66%|
|5 years (2016-10-14)||N/A|
Valuing Equitable stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Equitable's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Equitable's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.3 billion.
The EBITDA is a measure of a Equitable's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$9.8 billion|
|Gross profit TTM||$-2,016,000,000|
|Return on assets TTM||-0.2%|
|Return on equity TTM||-18.53%|
|Market capitalisation||$13.2 billion|
TTM: trailing 12 months
There are currently 9.7 million Equitable shares held short by investors – that's known as Equitable's "short interest". This figure is 61.3% up from 6.0 million last month.
There are a few different ways that this level of interest in shorting Equitable shares can be evaluated.
Equitable's "short interest ratio" (SIR) is the quantity of Equitable shares currently shorted divided by the average quantity of Equitable shares traded daily (recently around 2.8 million). Equitable's SIR currently stands at 3.43. In other words for every 100,000 Equitable shares traded daily on the market, roughly 3430 shares are currently held short.
However Equitable's short interest can also be evaluated against the total number of Equitable shares, or, against the total number of tradable Equitable shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Equitable's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Equitable shares in existence, roughly 20 shares are currently held short) or 0.0236% of the tradable shares (for every 100,000 tradable Equitable shares, roughly 24 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Equitable.
Find out more about how you can short Equitable stock.
Dividend payout ratio: 11.76% of net profits
Recently Equitable has paid out, on average, around 11.76% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.22% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Equitable shareholders could enjoy a 2.22% return on their shares, in the form of dividend payments. In Equitable's case, that would currently equate to about $0.69 per share.
While Equitable's payout ratio might seem low, this can signify that Equitable is investing more in its future growth.
Equitable's most recent dividend payout was on 19 August 2021. The latest dividend was paid out to all shareholders who bought their shares by 11 August 2021 (the "ex-dividend date").
Over the last 12 months, Equitable's shares have ranged in value from as little as $18.0088 up to $35.0671. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Equitable's is 1.6356. This would suggest that Equitable's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Equitable Holdings, Inc. , together with its consolidated subsidiaries, operates as a diversified financial services company worldwide. The company operates through four segments: Individual Retirement, Group Retirement, Investment Management and Research, and Protection Solutions. The Individual Retirement segment offers a suite of variable annuity products primarily to affluent and high net worth individuals. The Group Retirement segment provides tax-deferred investment and retirement services or products to plans sponsored by educational entities, municipalities, and not-for-profit entities, as well as small and medium-sized businesses. The Investment Management and Research segment offers diversified investment management, research, and related solutions to a range of clients through institutional, retail, and private wealth management channels; and distributes its institutional research products and solutions. The Protection Solutions segment provides a range of variable universal life, indexed universal life, and term life products to help affluent and high net worth individuals, as well as small and medium-sized business owners; and a suite of life, short- and long-term disability, dental, and vision insurance products to small and medium-size businesses.
Everything we know about the Aura Biosciences IPO, plus information on how to buy in.
Everything we know about the Claros Mortgage Trust IPO, plus information on how to buy in.
Everything we know about the Evotec SE IPO, plus information on how to buy in.
Everything we know about the Delimobil Holding SA IPO, plus information on how to buy in.
Everything we know about the Blue Water Vaccines IPO, plus information on how to buy in.
Everything we know about the Sonendo IPO, plus information on how to buy in.
Everything we know about the FlexEnergy Green Solutions IPO, plus information on how to buy in.
Everything we know about the Stran & Company IPO, plus information on how to buy in.
Everything we know about the Kidpik Corp IPO, plus information on how to buy in.
Everything we know about the Nuvectis Pharma IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.